NCT00358423View on ClinicalTrials.gov

The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Cystoid Macular Edema
Interventions
DRUG

Pegaptanib Sodium

0.3 mg/0.1 ml intravitreal injection, every 6 weeks, up to a total of 3 injections

DRUG

Control

Sham injections, every 6 weeks, up to a total of 3 sham injections

Trial Locations (1)

21287

The Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

Eyetech Pharmaceuticals
All Listed Sponsors
collaborator

Eyetech Pharmaceuticals

INDUSTRY

lead

Johns Hopkins University

OTHER